Currently, only one medication specifically targets female sexual dysfunction and holds FDA approval: Flibanserin (Addyi).
Flibanserin is a non-hormonal medication addressing hypoactive sexual desire disorder (HSDD) in premenopausal women. It’s important to understand that Flibanserin works differently than medications for male erectile dysfunction; it aims to increase sexual desire, not directly facilitate physical response.
Important Considerations Regarding Flibanserin
Before considering Flibanserin, it’s crucial to consult your doctor. This medication carries potential side effects, including dizziness, nausea, and sleepiness. It also interacts with other medications, such as alcohol and certain antidepressants. Your physician will assess your overall health and medication history to determine suitability.
Other Treatment Options
While Flibanserin is the only FDA-approved drug for HSDD, other treatments might be helpful. These include lifestyle modifications like stress reduction techniques, counseling, and addressing underlying medical conditions impacting libido. Your healthcare provider can discuss these alternatives and develop a personalized treatment plan.
| Flibanserin (Addyi) | Increases brain neurotransmitters related to sexual desire | Requires prescription; potential side effects; medication interactions |
| Counseling (Therapy) | Addresses psychological factors affecting sexual desire | Provides personalized support; may require multiple sessions |
| Lifestyle Changes | Improves overall health and well-being, indirectly affecting libido | Requires commitment; can include exercise, stress management, and improved sleep |
Remember to always speak with your healthcare provider before starting any new medication or treatment for sexual dysfunction. They can provide accurate information and personalized guidance based on your unique circumstances.
